Omentin polymorphism and its relations to bone mineral density in women

Archives of Medical Research

Volumn 46, Issue 3, 2015, Pages 173-180

  Boron, Dariusz ^a   Czerny, Boguslaw ^b,c   Bartkowiak Wieczorek, Joanna ^c,d   Sieron, Dominik ^e   Wolski, Hubert ^f  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c INSTITUTE OF NATURAL FIBRES AND MEDICINAL PLANTS   (Poland)

^d POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^e INSTITUTE OF ONCOLOGY   (Poland)

^f Division of Obstetrics and Gynecology Podhalanski Multidisciplinary Hospital Nowy Targ   (Poland)

Author keywords

Age; Gene ITLN 1 Intelectin 1 (intestinal lectin omentin); Osteoporosis; Polymorphism; Women

Indexed keywords

OMENTIN; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN;

ADULT; ARTICLE; BONE DENSITY; BONE MASS; BONE TURNOVER; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; POLAND; POSTMENOPAUSE OSTEOPOROSIS; BONE REMODELING; GENETICS; METABOLIC BONE DISEASE; MIDDLE AGED; OSTEOPOROSIS;

ADULT; BONE DENSITY; BONE DISEASES, METABOLIC; BONE REMODELING; CYTOKINES; FEMALE; GENOTYPE; GPI-LINKED PROTEINS; HUMANS; LECTINS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMORPHISM, GENETIC;

EID: 84942801132     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2015.03.012     Document Type: Article

References (34)

1. Yang RZ, Lee MJ, Hu H, et al. Identification of omentin as a novel depotspecific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006; 290:1253-1261.
2. Fain JN, Sacks HS, Buehrer B, et al. Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots. Int J Obes (Lond) 2008;32:810-815.
3. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2006;74:443-477.
4. Poulos SP, Hausman DB, Hausman GJ. The development and endocrine functions of adipose tissue. Mol Cell Endocrinol 2010;323: 20-34.
5. Xie H, Xie PL, Wu XP, et al. Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression. Cardiovasc Res 2011;92:296-306.
6. De Souza Batista CM, Yang RZ, Lee MJ, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007;56: 1655-1661.
7. Duan XY, Xie PL, Ma YL, et al. Omentin inhibits osteoblastic differentiation of calcifying vascular smooth muscle cells through the PI3K/Akt pathway. Amino Acids 2011;41:1223-1231.
8. Thommesen L, Stunes AK, Monjo M, et al. Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem 2006;99:824-834.
9. Xie H, Tang SY, Luo XH, et al. Insulin-like effects of visfatin on human osteoblasts. Calcif Tissue Int 2007;80:201-210.
10. Guo LJ, Jiang TJ, Liao L, et al. Relationship between serum omentin-1 level and bone mineral density in girls with anorexia nervosa. J Endocrinol Invest 2013;36:190-194.
11. Tohidi M, Akbarzadeh S, Larijani B, et al. Omentin-1, visfatin and adiponectin levels in relation to bone mineral density in Iranian postmenopausal women. Bone 2012;51:876-881.
12. Xie H, Xie PL, Luo XH, et al. Omentin-1 exerts bone-sparing effect in ovariectomized mice. Osteoporos Int 2012;23:1425-1436.
13. Schaffler A, Neumeier M, Herfarth H, et al. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 2005;1732:96-102.
14. Tsuji S, Uehori J, Matsumoto M, et al. Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. J Biol Chem 2001;276: 23456-23463.
15. Suzuki YA, Shin K, Lonnerdal B. Molecular cloning and functional expression of a human intestinal lactoferrin receptor. Biochemistry 2001;40:15771-15779.
16. Lee JK, Schnee J, Pang M, et al. Human homologs of the Xenopus oocyte cortical granule lectin XL35. Glycobiology 2001;11:65-73.
17. Zhou JY, Chan L, Zhou SW. Omentin: linking metabolic syndrome and cardiovascular disease. Curr Vasc Pharmacol 2014;12:136-143.
18. Ward KD, Klesges RC. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int 2001;68:259-270.
19. Straub RH, Cutolo M, Zietz B, et al. The process of aging changes the interplay of the immune, endocrine and nervous systems. Mech Ageing Dev 2001;122:1591-1611.
20. Xu XH, Dong SS, Guo Y, et al. Molecular genetic studies of gene identification for osteoporosis: the 2009 update. Endocr Rev 2010; 31:447-505.
21. Caetano-Lopes J, Canhao H, Fonseca JE. Osteoblasts and bone formation. Acta Reumatol Port 2007;32:103-110.
22. Seeman E, Delmas PD. Bone quality-the material and structural basis of bone strength and fragility. N Engl J Med 2006;354:2250-2261.
23. Wu SS, Liang QH, Liu Y, et al. Omentin-1 stimulates human osteoblast proliferation through PI3K/Akt signal pathway. Int J Endocrinol 2013;2013:368970.
24. Zillikens MC, Uitterlinden AG, van Leeuwen JP, et al. The role of body mass index, insulin, and adiponectin in the relation between fat distribution and bone mineral density. Calcif Tissue Int 2010;86: 116-125.
25. Jurimae J, Jurimae T, Leppik A, et al. The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women. J Bone Miner Metab 2008;26:618-623.
26. Morin S, Tsang JF, Leslie WD. Weight and body mass index predict bone mineral density and fractures in women aged 40 to 59 years. Osteoporos Int 2009;20:363-370.
27. Zhao LJ, Jiang H, Papasian CJ, et al. Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res 2008;23:17-29.
28. Zhao LJ, Liu YJ, Liu PY, et al. Relationship of obesity with osteoporosis. J Clin Endocrinol Metab 2007;92:1640-1646.
29. Splichal Z, Bienertova-Vasku J, Novak J, et al. The common polymorphism Val109Asp in the omentin gene is associated with daily energy intake in the Central-European population. Nutr Neurosci 2015;18:41-48.
30. SchäfflerA, ZeitounM, WobserH, et al. Frequency and significance of the novel single nucleotide missense polymorphismVal109Asp in the human gene encoding omentin inCaucasian patientswith type 2 diabetesmellitus or chronic inflammatory bowel diseases. Cardiovasc Diabetol 2007;6:3.
31. Yörük U, Yaykaşli KO, Ozhan H, et al. Association of omentin Val109Asp polymorphism with coronary artery disease. Anadolu Kardiyol Derg 2014;14:511-514.
32. Turan H, Yaykasli KO, Soguktas H, et al. Omentin serum levels and omentin gene Val109Asp polymorphism in patients with psoriasis. Int J Dermatol 2014;53:601-605.
33. Boroń D, Kamiński A, Kotrych D, et al. Polymorphism of vitamin D3 receptor and its relation to mineral bone density in perimenopausal women. Osteoporos Int 2015;26:1045-1052.
34. Boroń D, Agnieszka SM, Daniel K, et al. Polymorphism of interleukin-17 and its relation to mineral density of bones in perimenopausal women. Eur J Med Res 2014;19:69.